Treatment of Wilms tumor relapsing after initial treatment with vincristine, actinomycin D, and doxorubicin. A report from the national Wilms tumor study group

Pediatric Blood and Cancer

Volumn 50, Issue 2, 2008, Pages 236-241

  Malogolowkin, Marcio ^a,b   Cotton, Cecilia A ^c,d   Green, Daniel M ^e,f   Breslow, Norman E ^c,d   Perlman, Elizabeth ^g   Miser, James ^h,i   Ritchey, Michael L ^j   Thomas, Patrick R M ^k   Grundy, Paul E ^l   D'Angio, Giulio J ^m   Beckwith, J Bruce ⁿ   Shamberger, Robert C ^o,p   Haase, Gerald M ^q   Donaldson, Milton ^r   Weetman, Robert ^s,t   Coppes, Max J ^u   Shearer, Patricia ^v   Coccia, Peter ^w   Kletzel, Morris ^g,x   Macklis, Roger ^y   Tomlinson, Gail ^z   Huff, Vicki ^aa   Newbury, Robert ^ab   Weeks, Douglas ^h,i   more..

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Fred Hutchinson Cancer Research Center   (United States)

^e ROSWELL PARK CANCER INSTITUTE   (United States)

^f UNIVERSITY AT BUFFALO   (United States)

^g CHILDREN'S MEMORIAL HOSPITAL   (United States)

^h OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

ⁱ CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^j Pediatric Urology Associates   (United States)

^k ST JOSEPH HOSPITAL   (United States)

^l UNIVERSITY OF ALBERTA   (Canada)

^m HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

ⁿ LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o BOSTON CHILDREN S HOSPITAL   (United States)

^p HARVARD MEDICAL SCHOOL   (United States)

^q CHILDREN S HOSPITAL   (United States)

^r UMDNJ Robert Wood Johnson Medical School at Camden   (United States)

^s James Whitcomb Riley Children's Hospital   (United States)

^t INDIANA UNIVERSITY   (United States)

^u CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^v OCHSNER CLINIC FOUNDATION   (United States)

^w UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^x NORTHWESTERN UNIVERSITY   (United States)

^y LERNER RESEARCH INSTITUTE   (United States)

^z UNIVERSITY OF TEXAS AT DALLAS   (United States)

^aa UNIVERSITY OF TEXAS   (United States)

^ab UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Chemotherapy; Phase II clinical trials; Radiation oncology; Solid tumors; Wilms tumor (WT)

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; VINCRISTINE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HUMAN; INFANT; LUNG; MAJOR CLINICAL STUDY; MALE; NEPHROBLASTOMA; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR DIAGNOSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; DACTINOMYCIN; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; ETOPOSIDE; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY NEOPLASMS; MALE; NEOPLASM STAGING; RECURRENCE; WILMS TUMOR;

EID: 37549055839     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21267     Document Type: Article

References (30)

1. D'Angio GJ, Evans AE, Breslow N, et al. The treatment of Wilms' tumor. Results of the National Wilms' Tumor Study. Cancer 1976;38:633-646.
2. D'Angio GJ, Evans AE, Breslow N, et al. The treatment of Wilms' tumor. Results of the Second National Wilms' Tumor Study. Cancer 1981;47:2302-2311.
3. Lemerle J, Voute PA, Tournade MF, et al. Effectiveness of preoperative chemotherapy in Wilms' tumor: Results of an International Society of Pediatric Oncology (SIOP) clinical trial. J Clin Oncol 1983;1:604-609.
4. Grundy P, Breslow N, Green DM, et al. Prognostic factors for children with recurrent Wilms' tumor: Results from the Second and Third National Wilms' Tumor Study. J Clin Oncol 1989;7:638-647.
5. Pinkerton CR, Groot-Loonen JJ, Morris-Jones PH, et al. Response rates in relapsed Wilms' tumor. A need for new effective agents. Cancer 1991;67:567-571.
6. Malogolowkin MH, Bergman T, Seibel N, et al. Outcome and prognostic factors (PF) for patients with recurrent Wilms tumor (R-WT) - NWTS - 3 and 4 (NWTS 3,4). Proc Am Soc Clin Oncol 2001; abstract no. 3136 http://www.asco.org/ portal/site/ASCO/menuitem.34d60f5624ba07fd506fe310ee37a01d/?vgnextoid= 76f8201eb61a7010VgnVCM100000ed730ad1RCRD&vmview=abst_detail_view&confID= 10&abstractID=3136.
7. Grundy PE, Telzerow PE, Breslow N, et al. Loss of heterozygosity for chromosomes 16q and 1p in Wilms tumors predicts an adverse outcome. Cancer Res 1994;54:2331-2333.
8. Tournade MF, Lemerle J, Brunat-Mentigy M, et al. Ifosfamide is an active drug in Wilms' tumor: A phase II study conducted by the French Society of Pediatric Oncology. J Clin Oncol 1988;6:793-796.
9. Pein F, Pinkerton R, Tournade MF, et al. Etoposide in relapsed Wilms' tumor: A phase II study by the French Society of Pediatric Oncology. J Clin Oncol 1993;11:1478-1481.
10. Pein F, Tournade MF, Zucker JM, et al. Etoposide and carboplatin: A highly effective combination in relapsed or refractory Wilms' tumor - A phase II study by the French Society of Pediatric Oncology. J Clin Oncol 1994;12:931-936.
11. Baum ES, Gaynon P, Greenberg L, et al. Phase II trial of cisplatin in refractory childhood cancers: Children's Cancer Study Group report. Cancer Treat Rep 1981;65:815-822.
12. Douglass EC, Wilimas JA, Sackey K, et al. Efficacy of combination cisplatin (DDP) and VP-16 in the treatment of recurrent and advanced Wilms' tumors. Proc Am Soc Clin Oncol 1986;5:201 (abstr 789).
13. Loh W, Ortega JA, Wolff J, et al. Cisplatinum/VP-16 for the retrieval of Wilms' tumor relapsing on chemotherapy. Proc Am Soc Clin Oncol 1987;6:222. (abstr 876).
14. De Camargo B, Melarango R. Saba e Silva N, et al. Phase II study of carboplatin as a single drug for relapsed Wilms' tumor: Experience of the Brazilian Wilms' Tumor Study Group. Med Pediatr Oncol 1994;22:258-260.
15. Zoubek A, Kajtar P, Flucher-Wolfram B, et al. Response of untreated stage IV Wilms' tumor to single dose carboplatin assessed by "upfront" window therapy. Med Pediatr Oncol 1995;25:8-11.
16. Miser J, Krailo M, Hammond GD. The combination of ifosfamide, etoposide, and mesna: A very active regimen in the treatment of recurrent Wilms' tumor. Proc Am Soc Clin Oncol 1993;12:417 (abstr 1432).
17. Marina NM, Wilimas JA, Meyer WH, et al. Refining therapeutic strategies for patients with resistant Wilms' tumor. Am J Pediatr Hematol Oncol 1994;16:296-300.
18. Malogolowkin MH, Feusner J, Steele DA, et al. Carboplatin (CBDCA)/etoposide (VP-16) for the treatment of children with high-risk or recurrent Wilms' tumor. Proc Am Soc Clin Oncol 1994;13:424 (1453).
19. Murphy WM, Beckwith JB, Farrow GM. Tumours of the kidney, bladder, and related urinary structures. Atlas of tumor pathology, 3rd Series, Fascicle 11. Washington, DC: Armed Forces Institute of Pathology; 1994.
20. D'Angio GJ, Breslow N, Beckwith JB, et al. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer 1989;64:349-360.
21. Green D, Breslow N, Beckwith J, et al. A comparison between single dose and divided dose administration of dactinomycin and doxorubicin. A report from the National Wilms Tumor Study Group. J Clin Oncol 1998;16:237-245.
22. Pein F, Michon J, Valteau-Couanet D, et al. High-dose melphalan, etoposide, and carboplatin followed by autologous stem-cell rescue in pediatric high-risk recurrent Wilms' tumor: A French Society of Pediatric Oncology Study. J Clin Oncol 1998;16:3295-3301.
23. Green DM, Cotton CA, Malogolowkin M, et al. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D. A report from the National Wilms Tumor Study Group. Pediatr Blood Cancer 2007;48:493-499.
24. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;33:457-481.
25. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc (A) 1972;135:185-206.
26. Greenwood M. The natural duration of cancer. In: Reports on public health and medical subjects 33. London: Her Majesty's Stationery Office; 1926. pp 1-26.
27. Dome JS, Liu T, Krasin M, et al. Improved survival for patients with recurrent Wilms tumor: The experience at St. Jude Childrens Research Hospital. J Pediatr Hematol Oncol 2002;24:192-198.
28. Abu-Gosh AM, Krailo MD, Goldman SC, et al. Ifosfamide, carboplatin, and etoposide in children with poor-risk relapsed Wilms' Tumor: A Children's Cancer Group report. Ann Oncol 2002;13:460-469.
29. Kremens B, Grihn B, Klingebiel T, et al. High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma. Bone Marrow Transplant 2000;30:893-898.
30. Campbell AD, Cohn SL, Reynolds M, et al. Treatment of relapsed Wilms' tumor with high-dose therapy and autologous hematopoietic stem-cell rescue: The experience at Children's Memorial hospital. J Clin Oncol 2004;22:2885-2890.